Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Species-specific aspects in eukaryotic mRNA translation modulation and their implications in diseases

Project description

Species-specific mRNA translation mechanisms in human disease and infection

Translation of the genetic ‘recipe’ into the proteins it codes is a universally conserved process occurring primarily on ribosomes in the cytosol and mitochondria. However, species-specific structural and regulatory differences exist. The ERC-funded SpicTrans project will use structural and molecular biology methods to investigate species-specific components of mRNA translation modulation in mammals and in pathogenic parasites in the context of disease. This will include studying scanning of cytosolic mRNA for the start-codon and its alteration in colorectal cancer as well as differences in mitochondrial translation during the life cycle of a family of pathogenic parasites. Insight could inform treatments of human diseases and infections.

Objective

mRNA translation is a universally conserved process consisting on translating the genetic code into proteins, the primary building blocks of all living organisms. Translation is mainly operated by the ribosome, a hybrid molecule made of RNAs and proteins. In most eukaryotes, at least two types of mRNA translation coexist in nearly all cells. Indeed, although the quasi totality of the proteins is translated in the cytosol by the cytosolic ribosome, a small yet essential fraction of mRNA translation can take place in the mitochondria, the cell’s power plant. While mitochondrial translation process has proven to be substantially species-specific, numerous species-specific structural and regulatory differences also exist in the cytosolic translation process in spite of their relative conservation among eukaryotic species and are yet to be elucidated. We will use various structural and molecular biology methods to investigate, from a disease-related perspective, several species-specific aspects of mRNA translation modulation in mammals and in pathogenic parasites from the family of kinetoplastids. Namely, 1- we will investigate the molecular roles of several kinetoplastid-specific proteins involved in translation and evaluate their validity as pharmacophores. 2- We will study mitochondrial translation in kinetoplastids and focus on its variable regulation in different forms of the parasites during their life-cycle (blood vs. insect stages). 3- We will study cytosolic mRNA scanning for the start-codon during translation initiation to i) understand its molecular basis in different types of mRNAs (native and modified mRNAs, natural or artificial), ii) and investigate its alteration in colorectal cancer caused by the absence of a ribosomal RNA modification. Results will advance our knowledge of species-specific mRNA translation and open new perspectives for developing treatments against various human diseases and infections (anti-parasites, cancer therapy, mRNA vaccines).

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC - HORIZON ERC Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2022-COG

See all projects funded under this call

Host institution

UNIVERSITY OF HAMBURG
Net EU contribution
€ 899 539,00
Address
MITTELWEG 177
20148 Hamburg
Germany
Region
Hamburg Hamburg Hamburg
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 899 539,00

Beneficiaries (2)